Join Sally Barbour, PharmD, BCOP, CPP, FHOPA, from Duke Cancer Institute for this webinar in the 2018 NCCN Pharmacy Update Series on the topic The Evolving Landscape of Immunotherapy and Targeted Therapy for Non-Small Cell Lung Cancer.
The goal of this activity is to improve participants’ knowledge of and competence in applying immune checkpoint inhibitors in the treatment of patients with stage III NSCLC.
Join Sally Barbour, PharmD, BCOP, CPP, FHOPA, from Duke Cancer Institute for this webinar in the 2018 NCCN Pharmacy Update Series on the topic The Evolving Landscape of Immunotherapy and Targeted Therapy for Non-Small Cell Lung Cancer.
The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the targeted therapy and immunotherapy sections in the NCCN Guidelines. For the 2018 update, a new section on biomarkers was added.
The goal of this activity is to improve participants’ knowledge of and competence in applying immune checkpoint inhibitors in the treatment of patients with stage III NSCLC.
Jointly provided by NCCN and Clinical Care Options, LLC.
The goal of this activity is to improve participants’ knowledge of and competence in applying immune checkpoint inhibitors in the treatment of patients with stage III NSCLC.
The goal of this activity is to improve participants’ knowledge of and competence in applying immune checkpoint inhibitors in the treatment of patients with stage III NSCLC.
Join Bill Loo, MD, PhD and Natalie Lui, MD from Stanford Cancer Institute as they present their multidisciplinary expertise on a range of cases pertaining to early stage lung cancer.
Join James Stevenson, MD, and Sanjay Mukhopadhyay, MD, from Cleveland Clinic Taussig Cancer Institute as they present their multidisciplinary expertise on a range of cases pertaining to advanced lung cancer.
Join Bill Loo, MD, PhD and Natalie Lui, MD from Stanford Cancer Institute as they present their multidisciplinary expertise on a range of cases pertaining to early stage lung cancer.
Facebook
X
LinkedIn
Forward
